BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 9950223)

  • 1. Strain-specific recognition of live Leishmania donovani promastigotes by homologous antiserum raised against a crude membrane fraction of infected macrophages.
    Goel A; Vohra H; Varshney GC
    Parasitol Res; 1999 Jan; 85(1):19-24. PubMed ID: 9950223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipophosphoglycan masks recognition of the Leishmania donovani promastigote surface by human kala-azar serum.
    Karp CL; Turco SJ; Sacks DL
    J Immunol; 1991 Jul; 147(2):680-4. PubMed ID: 2071901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recognition of the parasite infected cell surface determinants by homologous antiserum raised against infected cell membranes.
    Choudhury A; Goel A; Raje M; Vohra H; Varshney GC
    Parasitol Res; 1997; 83(8):746-54. PubMed ID: 9342738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of a repeating phosphorylated disaccharide lipophosphoglycan epitope on the surface of macrophages infected with Leishmania donovani.
    Tolson DL; Turco SJ; Pearson TW
    Infect Immun; 1990 Nov; 58(11):3500-7. PubMed ID: 1699895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immuno stimulating glycophosphosphingolipid antigen from Leishmania donovani is recognized by visceral leishmaniasis patient sera.
    Bhaumik SK; Singh MK; Karmakar S; De T
    Mol Biochem Parasitol; 2008 Jun; 159(2):121-9. PubMed ID: 18405984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infectivity of Leishmania promastigotes is associated with surface antigenic expression.
    Rizvi FS; Afchain D; Sherlock I; Sadigursky M; Capron A; Santoro F
    Immunol Lett; 1985; 11(5-6):317-23. PubMed ID: 3912320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pure protein from Leishmania donovani protects mice against both cutaneous and visceral leishmaniasis.
    Rachamim N; Jaffe CL
    J Immunol; 1993 Mar; 150(6):2322-31. PubMed ID: 8450215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of entry of virulent and avirulent strains of Leishmania donovani into macrophages: a possible role of virulence molecules (gp63 and LPG).
    Chakrabarty R; Mukherjee S; Lu HG; McGwire BS; Chang KP; Basu MK
    J Parasitol; 1996 Aug; 82(4):632-5. PubMed ID: 8691373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Species and stage specificity of Leishmania donovani antigens.
    White AC; Hanham C
    J Parasitol; 1991 Feb; 77(1):142-50. PubMed ID: 1704058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serodiagnostic and immunoprophylactic potential of a 78kDa protein of Leishmania donovani of Indian origin.
    Mukherjee M; Bhattacharyya A; Duttagupta S
    Med Sci Monit; 2002 Apr; 8(4):BR117-22. PubMed ID: 11951057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibody affinity purification of a 78 kDa membrane protein of Leishmania donovani of Indian origin and its role in host-parasite interaction.
    Mukherjee M; Bhattacharyya A; Duttagupta S
    J Biosci; 2002 Dec; 27(7):665-72. PubMed ID: 12571371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leishmania donovani flagellum-specific epitopes mediating host-parasite interactions.
    Singla N; Vinayak VK
    FEMS Immunol Med Microbiol; 1994 Mar; 8(3):175-81. PubMed ID: 7516230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of two proteins from Leishmania donovani and their use for vaccination against visceral leishmaniasis.
    Jaffe CL; Rachamim N; Sarfstein R
    J Immunol; 1990 Jan; 144(2):699-706. PubMed ID: 2295807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parasite accessory cell interactions in murine leishmaniasis. I. Evasion and stimulus-dependent suppression of the macrophage interleukin 1 response by Leishmania donovani.
    Reiner NE
    J Immunol; 1987 Mar; 138(6):1919-25. PubMed ID: 3493291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membrane surface of Mycobacterium microti-infected macrophages antigenically differs from that of uninfected macrophages.
    Majumdar S; Kaur H; Vohra H; Varshney GC
    FEMS Immunol Med Microbiol; 2000 May; 28(1):71-7. PubMed ID: 10767610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leishmania donovani: CD2 biased immune response skews the SAG mediated therapy for a predominant Th1 response in experimental infection.
    Bimal S; Sinha S; Singh SK; Narayan S; Kumar V; Verma N; Ranjan A; Sinha PK; Das VN; Pandey K; Kar SK; Das P
    Exp Parasitol; 2012 Jul; 131(3):274-82. PubMed ID: 22580024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of leishmania antigen in kala azar patients using monoclonal antibodies.
    Sinha R; Arora SK; Datta U; Sehgal S
    Microbiol Immunol; 1992; 36(4):391-400. PubMed ID: 1406366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A parasite rescue and transformation assay for antileishmanial screening against intracellular Leishmania donovani amastigotes in THP1 human acute monocytic leukemia cell line.
    Jain SK; Sahu R; Walker LA; Tekwani BL
    J Vis Exp; 2012 Dec; (70):. PubMed ID: 23299097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of amastigote-specific antigens of Leishmania donovani using kala-azar patient sera.
    Gupta N; Goyal N; Bhatia N; Kamboj KK; Rastogi AK
    Indian J Exp Biol; 2001 Jul; 39(7):623-8. PubMed ID: 12019753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective in vitro inhibition of Leishmania donovani by a semi-purified fraction of wild mushroom Grifola frondosa.
    Sultana SS; Ghosh J; Chakraborty S; Mukherjee D; Dey S; Mallick S; Dutta A; Paloi S; Khatua S; Dutta T; Bhattacharya S; Acharya K; Ghorai N; Pal C
    Exp Parasitol; 2018 Sep; 192():73-84. PubMed ID: 30040961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.